Clinical Features of Parkinson's Disease Flashcards

State the motor and non-motor features of PD Understand and discuss the rational basis for drug treatments of PD and the main complications of treatment Appreciate and discuss the non-medication based aspects of PD management, relating both to the patient, family, carers, and society at large

1
Q

Name the four core features of Parkinson’s disease

A

Pill-rolling tremor, rigidity, bradykinesia, and loss of postural reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name four domains affected by Parkinson’s disease

A

Motor, neuropsychiatric, autonomic, and sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give at least 4 motor symptoms of Parkinson’s disease

A

Tremor, rigidity, akinesia, bradykinesia, clumsiness, loss of postural reflexes, falls, dystonia, cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give at least 4 neuropsychiatric symptoms of Parkinson’s disease

A

Hallucinations, anxiety, confusion, stupor, impulsivity, depression, cognitive decline, dementia, paranoia, visuospatial dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give at least 4 autonomic and vegetative symptoms of Parkinson’s disease

A

Bladder and bowel dysfunction, hypotension, impotence dysarthria, dysphagia, drooling, rash, anosmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give at least 4 sleep symptoms of Parkinson’s disease

A

Restless leg syndrome, REM sleep disorder, nightmares, nocturia, periodic limb movement disorder, immobility, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give 2 classes of drugs which can cause parkinsonism

A

Dopamine blockers and calcium blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where does Parkinson’s disease pathology typically start?

A

The dorsal basal nucleus and vagus nerve, and the olfactory system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name 2 other alpha-synucleinopathies

A

Dementa with Lewy bodies and multiple system atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name the 3 disorders encompassed by multiple system atrophy

A

Olivopontocerebellar atrophy (OPCA), striatonigral degeneration, and Shy-Drager syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name 2 tauopathies which cause parkinsonism

A

Corticobasal degeneration and progressive supranuclear palsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State the prevalence of Parkinson’s disease

A

0.2-0.4%, increasing with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State the prevalence of Parkinson’s disease in those over 65

A

2-3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Degeneration of which systems produces motor symptoms?

A

Substantia nigra and pedunculopontine nucleus (PPN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Degeneration of which systems produces sleep symptoms?

A

Hypothalamus, pedunculopontine nucleus (PPN), thalamus, raphe nucleus, RAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Degeneration of which systems produces autonomic symptoms?

A

Hypothalamus, medullary nuclei, spinal cord, peripheral ganglia

17
Q

Degeneration of which systems produces cognitive symptoms?

A

Substantia vigra, ventral tegmental area (VTA), locus coeruleus, raphe nucleus, basal forebrain, limbic system, hippocampus, cerebral cortex, thalamus

18
Q

Degeneration of which systems produces sensory symptoms?

A

Olfactory pathway, visual pathway, association cortex

19
Q

Name the 2 main neurotransmitter’s involved in Parkinson’s disease

A

Dopamine and acetylcholine

20
Q

Name 2 indirect dopamine agonists used in Parkinson’s disease

A

L-DOPA (dopamine precursor) and amantadine (increases dopamine release)

21
Q

Name at least 2 direct dopamine agonists used in Parkinson’s disease

A

Apomorphine, pramipexole, ropinirole, rotigotine

22
Q

Name at least 2 COMT inhibitors used in Parkinson’s disease

A

Entacapone, tolcapone, opicapone

23
Q

Name 2 MAO inhibitors used in Parkinson’s disease

A

Selegiline, rasagiline

24
Q

Why must levodopa be co-administered with a decarboxylase inhibitor?

A

To prevent it being converted to dopamine outside of the CNS

25
How much levodopa reaches the brain?
Less than 5%
26
Why can dextrodopa not be used?
It causes haematological toxicity
27
Name 2 sustained release levodopa formulations and the symptom group they are most effective for
POS: Increased active time, tends to improve sleep NEG: Slow active onset, tends to improve dyskinesia
28
Why should levodopa be avoided in younger patients
To delay the development of tolerance
29
State some side effects of dopamine agonists
Nausea, vomiting, hypotension, somnolence, sleep attacks
30
What is the most common autonomic symptom of PD?
Constipation
31
Which antipsychotics can be used in PD?
Clonazepam, quetiapine, aripiprazole, or clozapine
32
What is the most common neuropsychiatric symptom of PD?
Confusion and agitation
33
What percentage of PD patients experience memory loss?
50%
34
Give 2 palliative treatments for treatment-resistant PD
Deep brain stimulation or high-energy ultrasound